Last $20.19 USD
Change Today -0.09 / -0.44%
Volume 342.9K
EPZM On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/15/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert J. Gould Ph.D.

Chief Executive Officer and Director, Epizyme, Inc.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 2 different organizations across 2 different industries.

See Board Relationships
58$2,266,506
As of Fiscal Year 2013

Background*

Dr. Robert J. Gould, Ph.D., has been the Chief Executive Officer of Epizyme, Inc. since March 2010. Dr. Gould served as the President of Epizyme, Inc. since March 2010 until July 2013. Dr. Gould served as the Vice President of Licensing and External Research at Merck Research Labs until 2006. Dr. Gould served as Vice President of Basic Research at Merck Research Labs, where he oversaw strategic direction and drug discovery activities for multiple therapeutic areas, as ...

Read Full Background

Corporate Headquarters*

400 Technology Square
Cambridge, Massachusetts 02139

United States

Phone: 617-229-5872
Fax: 617-349-0707

Board Members Memberships*

2008-Present
Chief Executive Officer and Director

Education*

PhD
University of Iowa
Bachelor's Degree 1981
University of Iowa
BA 1976
Spring Arbor University

Other Affiliations*

Annual Compensation*

Salary$387,668
Bonus$177,022
Total Annual Compensation$564,690

Stock Options*

All Other Compensation$1,995
Exercisable Options897,223
Unexercisable Options391,743
Total Number of Options1,288,966

Total Compensation*

Total Annual Cash Compensation$566,685
Total Short Term Compensation$564,690
Other Long Term Compensation$1,995
Total Calculated Compensation$2,266,506
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EPZM:US $20.19 USD -0.09

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EPIZYME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.